Analyst Rating: Will Assembly Biosciences Inc (ASMB) Stock Do Better Than the Market? – InvestorsObserver

Date:

- Advertisement -

Analysts who follow Assembly Biosciences Inc (ASMB) on average expect it to rise 79.92% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Assembly Biosciences Inc an Analyst Ranking of 20, which means it ranks higher than 20 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.5
Wall Street analysts are rating ASMB a Buy today. Find out what this means to you and get the rest of the rankings on ASMB!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company’s balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What’s Happening With Assembly Biosciences Inc Stock Today?

Assembly Biosciences Inc (ASMB) stock is up 12.82% while the S&P 500 is down -0.69% as of 11:41 AM on Monday, Dec 19. ASMB has risen $0.15 from the previous closing price of $1.17 on volume of 611,694 shares. Over the past year the S&P 500 has fallen -16.25% while ASMB is down -41.85%. ASMB lost -$2.80 per share the over the last 12 months. Click Here to get the full Stock Report for Assembly Biosciences Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy

source

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

ADVERTISEMENT

Popular

More like this
Related

IMF predicts global public debt will be at 93% of GDP by end of 2024

Global public debt will exceed US$100 trillion by the...

World Bank’s Banga says more bilateral debt forgiveness needed

World Bank President Ajay Banga said on Thursday (17...

Ghana, creditor panel agree on debt restructuring, paving way for IMF cash

Ghana has finalised a pact with its official creditor...

Nigeria strikes deal with Shell to supply $3.8 billion methanol project

Nigeria has struck a deal for Shell (SHEL.L), opens new...